NCT02196662View on ClinicalTrials.gov

Pharmacokinetics of IBD98-M 400mg-57.5/Day in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Healthy
Interventions
DRUG

IBD98-M:

single adiministration

DRUG

IBD98-M without HA

single adiministration

DRUG

Delzicol

single adiministration

Trial Locations (1)

G1P0A2

inVentiv Health Clinique, Québec

Sponsors
All Listed Sponsors
lead

Holy Stone Healthcare Co., Ltd

INDUSTRY